C.K. Allerston

994 total citations
20 papers, 693 citations indexed

About

C.K. Allerston is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, C.K. Allerston has authored 20 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in C.K. Allerston's work include DNA Repair Mechanisms (4 papers), CRISPR and Genetic Engineering (3 papers) and Receptor Mechanisms and Signaling (3 papers). C.K. Allerston is often cited by papers focused on DNA Repair Mechanisms (4 papers), CRISPR and Genetic Engineering (3 papers) and Receptor Mechanisms and Signaling (3 papers). C.K. Allerston collaborates with scholars based in United Kingdom, United States and Japan. C.K. Allerston's co-authors include O. Gileadi, F. von Delft, J.A. Newman, David L. Selwood, Ian Phillips, Elizabeth A. Shephard, Christopher J. Schofield, C.D.O. Cooper, Peter J. McHugh and P. Savitsky and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

C.K. Allerston

20 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.K. Allerston United Kingdom	14	505	108	104	88	53	20	693
Christopher D. Kane United States	17	576 1.1×	113 1.0×	124 1.2×	95 1.1×	55 1.0×	31	956
Jacky Chi Ki Ngo Hong Kong	19	893 1.8×	81 0.8×	109 1.0×	63 0.7×	87 1.6×	45	1.2k
Lisa L. Gallegos United States	9	629 1.2×	90 0.8×	61 0.6×	55 0.6×	50 0.9×	13	785
K. Maly Austria	16	527 1.0×	94 0.9×	99 1.0×	57 0.6×	43 0.8×	28	665
Christine M. Gould United States	9	794 1.6×	89 0.8×	75 0.7×	66 0.8×	71 1.3×	10	963
Shuiliang Yu United States	18	592 1.2×	85 0.8×	60 0.6×	88 1.0×	68 1.3×	25	796
Chuong Nguyen United States	12	379 0.8×	81 0.8×	72 0.7×	48 0.5×	17 0.3×	17	610
Joan R. Kanter United States	13	547 1.1×	67 0.6×	72 0.7×	61 0.7×	25 0.5×	16	757
Levi L. Blazer United States	21	867 1.7×	86 0.8×	126 1.2×	45 0.5×	72 1.4×	38	1.1k
Silvia Franchini Italy	17	546 1.1×	103 1.0×	196 1.9×	69 0.8×	20 0.4×	56	1.2k

Countries citing papers authored by C.K. Allerston

Since Specialization

Citations

This map shows the geographic impact of C.K. Allerston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.K. Allerston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.K. Allerston more than expected).

Fields of papers citing papers by C.K. Allerston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.K. Allerston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.K. Allerston. The network helps show where C.K. Allerston may publish in the future.

Co-authorship network of co-authors of C.K. Allerston

This figure shows the co-authorship network connecting the top 25 collaborators of C.K. Allerston. A scholar is included among the top collaborators of C.K. Allerston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.K. Allerston. C.K. Allerston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gómez, Eliana B, Kevin Ebata, Mary S. Rosendahl, et al.. (2023). Pirtobrutinib preclinical characterization: a highly selective, non-covalent (reversible) BTK inhibitor. Blood. 142(1). 62–72. 56 indexed citations

Nguyen, Jasmine, Juping Liu, Paweł Stańczak, et al.. (2017). Method for rapid optimization of recombinant GPCR protein expression and stability using virus-like particles. Protein Expression and Purification. 133. 41–49. 10 indexed citations

Nguyen, Jasmine, Juping Liu, Paweł Stańczak, et al.. (2017). Dataset on Galanin Receptor 3 mutants that improve recombinant receptor expression and stability in an agonist and antagonist bound form. Data in Brief. 12. 603–607. 2 indexed citations

Couñago, Rafael M., C.K. Allerston, P. Savitsky, et al.. (2017). Structural characterization of human Vaccinia-Related Kinases (VRK) bound to small-molecule inhibitors identifies different P-loop conformations. Scientific Reports. 7(1). 7501–7501. 25 indexed citations

Levy, Shiri, et al.. (2016). Identification of LACTB2, a metallo-β-lactamase protein, as a human mitochondrial endoribonuclease. Nucleic Acids Research. 44(4). 1813–1832. 36 indexed citations

Allerston, C.K., Sook Y. Lee, J.A. Newman, et al.. (2015). The structures of the SNM1A and SNM1B/Apollo nuclease domains reveal a potential basis for their distinct DNA processing activities. Nucleic Acids Research. 43(22). 11047–11060. 32 indexed citations

Newman, J.A., P. Savitsky, C.K. Allerston, et al.. (2015). Crystal structure of the Bloom's syndrome helicase indicates a role for the HRDC domain in conformational changes. Nucleic Acids Research. 43(10). 5221–5235. 75 indexed citations

Cooper, C.D.O., J.A. Newman, H. Aitkenhead, C.K. Allerston, & O. Gileadi. (2015). Structures of the Ets Protein DNA-binding Domains of Transcription Factors Etv1, Etv4, Etv5, and Fev. Journal of Biological Chemistry. 290(22). 13692–13709. 40 indexed citations

Mota, Filipa, et al.. (2015). A new small molecule inhibitor of soluble guanylate cyclase. Bioorganic & Medicinal Chemistry. 23(17). 5303–5310. 13 indexed citations

10.

Mota, Filipa, et al.. (2014). Surface plasmon resonance using the catalytic domain of soluble guanylate cyclase allows the detection of enzyme activators. Bioorganic & Medicinal Chemistry Letters. 24(4). 1075–1079. 7 indexed citations

11.

Bhargava, Yogesh, Konstantina Chachlaki, Katherine C. Wood, et al.. (2013). Improved genetically-encoded, FlincG-type fluorescent biosensors for neural cGMP imaging. Frontiers in Molecular Neuroscience. 6. 26–26. 32 indexed citations

12.

Allerston, C.K., F. von Delft, & O. Gileadi. (2013). Crystal Structures of the Catalytic Domain of Human Soluble Guanylate Cyclase. PLoS ONE. 8(3). e57644–e57644. 68 indexed citations

13.

Shimizu, Makiko, C.K. Allerston, Elizabeth A. Shephard, Hiroshi Yamazaki, & Ian Phillips. (2013). Relationships between flavin‐containing mono‐oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population. British Journal of Clinical Pharmacology. 77(5). 839–851. 21 indexed citations

14.

Gileadi, O., C.K. Allerston, & F. von Delft. (2013). Crystal structures of human soluble guanylate cyclase catalytic domains: promiscuity of the dimer interface and a potential allosteric site. BMC Pharmacology and Toxicology. 14(S1). 1 indexed citations

15.

Sengerová, Blanka, C.K. Allerston, Sook Y. Lee, et al.. (2012). Characterization of the Human SNM1A and SNM1B/Apollo DNA Repair Exonucleases. Journal of Biological Chemistry. 287(31). 26254–26267. 43 indexed citations

16.

Keates, Tracy, C.D.O. Cooper, P. Savitsky, et al.. (2011). Expressing the human proteome for affinity proteomics: optimising expression of soluble protein domains and in vivo biotinylation. New Biotechnology. 29(5). 515–525. 20 indexed citations

17.

Jarvis, Ashley, C.K. Allerston, Haiyan Jia, et al.. (2010). Small Molecule Inhibitors of the Neuropilin-1 Vascular Endothelial Growth Factor A (VEGF-A) Interaction. Journal of Medicinal Chemistry. 53(5). 2215–2226. 165 indexed citations

18.

Allerston, C.K., et al.. (2009). A novel mutation in the flavin-containing monooxygenase 3 gene (FMO3) of a Norwegian family causes trimethylaminuria. Molecular Genetics and Metabolism. 98(1-2). 198–202. 8 indexed citations

19.

Allerston, C.K., Makiko Shimizu, Masaki Fujieda, et al.. (2007). Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3). Pharmacogenetics and Genomics. 17(10). 827–839. 31 indexed citations

20.

Allerston, C.K., Werner G. Krebs, Weifeng Li, et al.. (2003). THE STATUS OF STRUCTURAL GENOMICS DEFINED THROUGH THE ANALYSIS OF CURRENT TARGETS AND STRUCTURES. PubMed. 375–386. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact